FigureAsia 35 Under 35 · Healthcare
Khet Singh Rajpurohit
Age 29 · Health-insurance claims and patient financing · Bengaluru, India
Founder whose claims platform grew from more than 250 hospitals in May 2025 to about 450 by January 2026, while processing 8,000–9,000 monthly claims.
- Approximate age at 31 December 2025
- 29
- Field
- Healthcare
- Country or region
- Bengaluru, India
- FigureAsia U35 Assessment
- 89.5 / 100
Profile
Career and documented record
Khet Singh Rajpurohit works on a part of healthcare that patients encounter at their most vulnerable: whether paperwork, authorization or a deposit delays treatment. In May 2025, the platform he cofounded served more than 250 hospitals across seven cities and had facilitated claims for more than 35,000 patients. By January 2026, reporting placed the network at roughly 450 hospitals and 8,000–9,000 claims per month — an approximately 80% increase in hospital coverage across the interval.
The model standardizes documentation, follows the claims lifecycle and offers interest-free reimbursement financing intended to reduce deposit barriers. Rajpurohit's agency is grounded in fieldwork: he spent time at hospital billing desks to map where claims fail before translating the workflow into software.
The public record does not yet provide an independent comparison of rejection rates, approval time, out-of-pocket cost or health outcomes. Some company pages show older, lower figures, which may reflect stale content or different definitions. FigureAsia recognizes the scale of an underexamined access intervention while keeping the evidence standard higher than a network count.
FigureAsia selection
Why Khet Singh Rajpurohit is on the list
FigureAsia selected Rajpurohit because administrative friction can determine whether insured care is actually reachable. His 2025–2026 growth is measurable, his personal understanding of hospital workflow is documented and the model addresses a structural problem in an expanding insurance market. The score is restrained by the absence of audited performance and patient-outcome comparisons.
Verified work
The 2025–26 record
Principal milestone
Approximately 450 hospitals reported by January 2026
Evidence record
8,000–9,000 claims per month reported
Scale or implementation
About 80% growth in hospital coverage from May 2025 to January 2026
Field context
The work in its field
Within health-insurance claims and patient financing, the relevant test is whether a result can survive scrutiny of maturity, attribution, validity and practical fit. That distinction matters: completed evidence is not projected benefit, and individual responsibility is not interchangeable with the wider team’s achievement.
FigureAsia U35 Assessment
Assessment breakdown
89.5out of 100
Substantive 2025–2026 contribution
18 / 20
The score reflects completed 2025–26 work in health-insurance claims and patient financing, assessed at the documented maturity of deployed hospital claims infrastructure.
Verified impact
13.5 / 15
Impact credit is limited to the measured study, regulatory, implementation or operating record stated in the profile; unsupported patient benefit is excluded.
Originality and distinction
9 / 10
The work creates or materially advances a distinctive capability within health-insurance claims and patient financing rather than relying on title or institutional association.
Field and industry influence
8 / 10
The assessment recognises demonstrated effects on research, product development, care delivery or professional practice, with publicity alone carrying no weight.
Individual agency
10 / 10
Named authorship and the documented role of Cofounder establish individual responsibility while preserving credit for collaborators.
Durability and trajectory
4.5 / 5
The cited work forms part of a continuing programme, platform or research trajectory rather than a single uncompleted announcement.
Asian significance and global relevance
5 / 5
The Asian connection is material to the person's identity, operating base or populations served: Indian founder operating across Indian hospital networks.
Clinical and scientific validity
4.9 / 7
Clinical and scientific validity is calibrated to deployed hospital claims infrastructure, with the profile retaining the evidence boundary attached to the result.
Safety, quality and responsible governance
5.6 / 7
Safety and governance credit reflects accurate regulatory language, study limitations, data stewardship and the refusal to turn early evidence into clinical certainty.
Translation and care-pathway fit
6 / 6
The work is scored for its demonstrated fit with a laboratory, regulatory, clinical, operational or public-health pathway, not for projected future adoption.
Access, equity and resource stewardship
5 / 5
Access credit reflects documented reach, capacity, affordability or inclusion while distinguishing service volume from proven clinical outcome.